EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

Clinical trial NCT05444894 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05444894
Sponsor: Editas Medicine, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Transfusion Dependent Beta Thalassemia Hemoglobinopathies Thalassemia Major Thalassemia Intermedia

Start date: 2022-04-29
Primary completion: 2025-09-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.